Hospital
Palisades Medical Center INC
Palisades Medical Center INC was paid $7.93M by Medicaid between Jan 2018 and Sep 2018, across 202 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.
33Billing provider infoPALISADES MEDICAL CENTER INC
NORTH BERGEN, NJ 07047
NORTH BERGEN, NJ 07047
33aNPI1093736001assigned 07/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.93M
24GClaims120,141
24DCodes billed202
24AFirst – last monthJan 2018 – Sep 2018
Compared with peers
Next to other General Acute Care Hospital providers in New Jersey
Rank by total paid#63 of 93
Median peer was paid$30.60M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 120,141 | $7.93M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 3,782 | 3,422 | $1.30M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 4,453 | 4,298 | $1.20M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.4% | 1,422 | 1,363 | $429K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4.8% | 3,565 | 760 | $384K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 4.7% | 3,183 | 1,784 | $376K |
| G0378 | Hospital observation service, per hour | 4.0% | 839 | 767 | $317K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 3.5% | 225 | 225 | $279K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.4% | 3,964 | 1,039 | $189K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 746 | 733 | $157K |
| 95782 | 1.9% | 105 | 105 | $147K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 440 | 439 | $118K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 1,617 | 1,525 | $102K |
190 more codes
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.3% | 2,803 | $101K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.3% | 136 | $99K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 834 | $89K |
| 80053 | Comprehensive metabolic panel | 1.1% | 4,852 | $88K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 4,883 | $80K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.0% | 1,200 | $80K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 816 | $77K |
| 90863 | <1% | 468 | $75K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,636 | $73K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,904 | $72K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 270 | $66K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,280 | $64K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 86 | $63K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 478 | $61K |
| OP250 | <1% | 8,498 | $54K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,757 | $52K |
| 59025 | Fetal non-stress test | <1% | 399 | $50K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,116 | $48K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 832 | $47K |
| 76818 | <1% | 279 | $47K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 279 | $46K |
| 76801 | <1% | 419 | $43K | |
| 97010 | <1% | 2,371 | $40K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,275 | $39K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 177 | $38K |
| 76830 | Ultrasound, transvaginal | <1% | 281 | $34K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 572 | $34K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,012 | $33K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 211 | $30K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 265 | $28K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 254 | $27K |
| 82948 | <1% | 1,752 | $26K | |
| A9270 | Non-covered item or service | <1% | 164 | $26K |
| 84484 | <1% | 1,299 | $26K | |
| 85610 | <1% | 1,662 | $26K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 153 | $25K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 253 | $25K |
| 62323 | <1% | 27 | $25K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 391 | $25K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 862 | $25K |
| 85730 | <1% | 1,509 | $24K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 390 | $23K |
| 82553 | <1% | 1,189 | $23K | |
| OP272 | <1% | 1,382 | $22K | |
| 97161 | <1% | 425 | $22K | |
| 82550 | <1% | 1,241 | $22K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 807 | $22K |
| 95811 | <1% | 24 | $20K | |
| 83735 | <1% | 889 | $20K | |
| 81001 | <1% | 1,897 | $19K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 211 | $19K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,206 | $19K |
| 87400 | <1% | 1,681 | $19K | |
| 93017 | <1% | 125 | $16K | |
| 92523 | <1% | 137 | $16K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 219 | $15K |
| 76813 | <1% | 120 | $15K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 245 | $15K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,037 | $14K |
| 83880 | <1% | 643 | $14K | |
| 81003 | <1% | 1,355 | $14K | |
| 96367 | <1% | 316 | $13K | |
| 84703 | <1% | 2,548 | $13K | |
| 87040 | <1% | 524 | $13K | |
| OP370 | <1% | 695 | $13K | |
| 70486 | <1% | 65 | $13K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 733 | $13K |
| 83605 | <1% | 551 | $12K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 72 | $11K |
| OP710 | <1% | 343 | $11K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 122 | $11K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 102 | $11K |
| 84100 | <1% | 325 | $11K | |
| 97016 | <1% | 333 | $10K | |
| 73610 | <1% | 226 | $10K | |
| 97165 | <1% | 107 | $10K | |
| 73562 | <1% | 252 | $10K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 30 | $10K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 164 | $9K |
| 97116 | <1% | 323 | $9K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 26 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 525 | $9K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 212 | $9K |
| 73630 | <1% | 245 | $9K | |
| 83690 | <1% | 1,286 | $9K | |
| 93970 | <1% | 52 | $9K | |
| 85027 | <1% | 623 | $9K | |
| 73130 | <1% | 204 | $8K | |
| 97162 | <1% | 146 | $8K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 154 | $8K |
| 87070 | <1% | 1,067 | $8K | |
| 72100 | <1% | 236 | $8K | |
| 77080 | <1% | 80 | $8K | |
| 73030 | <1% | 180 | $7K | |
| 80061 | Lipid panel | <1% | 512 | $7K |
| OP258 | <1% | 814 | $7K | |
| 86900 | <1% | 416 | $6K | |
| 80306 | <1% | 401 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 208 | $6K |
| 76536 | <1% | 57 | $6K | |
| 80320 | <1% | 521 | $6K | |
| 74241 | <1% | 88 | $6K | |
| 84702 | <1% | 400 | $6K | |
| 71250 | <1% | 51 | $5K | |
| 76770 | <1% | 60 | $5K | |
| 76642 | <1% | 68 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 85 | $5K |
| 86850 | <1% | 196 | $4K | |
| 87077 | <1% | 249 | $4K | |
| 77066 | Tomosynthesis, mammo | <1% | 40 | $4K |
| 87420 | <1% | 429 | $4K | |
| OP270 | <1% | 435 | $4K | |
| 12011 | <1% | 90 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 34 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 409 | $4K |
| T2034 | Crisis intervention, waiver; per diem | <1% | 13 | $4K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 95 | $4K |
| 73110 | <1% | 126 | $4K | |
| 82150 | <1% | 455 | $3K | |
| 86901 | <1% | 200 | $3K | |
| 87186 | <1% | 206 | $3K | |
| 73502 | <1% | 87 | $3K | |
| 82607 | <1% | 128 | $3K | |
| 51701 | <1% | 67 | $3K | |
| 96368 | <1% | 68 | $3K | |
| 82746 | <1% | 122 | $2K | |
| 77065 | Tomosynthesis, mammo | <1% | 42 | $2K |
| 73080 | <1% | 67 | $2K | |
| 87185 | <1% | 123 | $2K | |
| 93971 | <1% | 14 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 160 | $2K |
| 96376 | <1% | 44 | $2K | |
| 85651 | <1% | 113 | $2K | |
| 82728 | <1% | 79 | $2K | |
| J3490 | Unclassified drugs | <1% | 143 | $2K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 31 | $2K |
| 90715 | <1% | 108 | $2K | |
| 82570 | <1% | 153 | $2K | |
| 84439 | <1% | 173 | $2K | |
| 85378 | <1% | 112 | $1K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 104 | $1K |
| 73090 | <1% | 39 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 53 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 53 | $1K |
| 83550 | <1% | 89 | $1K | |
| 83540 | <1% | 103 | $1K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 158 | $1K |
| 12001 | <1% | 32 | $1K | |
| 88304 | <1% | 57 | $1K | |
| 82043 | <1% | 104 | $989.21 | |
| 74019 | <1% | 27 | $975.14 | |
| 93880 | <1% | 15 | $811.16 | |
| 97597 | <1% | 15 | $733.44 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 629 | $707.25 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 57 | $686.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 537 | $673.07 |
| 73590 | <1% | 12 | $667.34 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 466 | $643.62 |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 33 | $638.62 |
| 80076 | <1% | 134 | $638.40 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | <1% | 146 | $596.25 |
| 85044 | <1% | 14 | $561.07 | |
| 76857 | <1% | 17 | $556.67 | |
| 73060 | <1% | 12 | $546.30 | |
| 88300 | <1% | 39 | $535.40 | |
| 29125 | <1% | 12 | $511.27 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 30 | $416.93 |
| 71101 | <1% | 12 | $334.13 | |
| 88313 | <1% | 12 | $317.70 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 184 | $279.40 |
| 80329 | <1% | 13 | $267.92 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 43 | $221.95 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 44 | $207.37 |
| G8997 | Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 13 | $173.34 |
| G8996 | Swallowing functional limitation, current status at therapy episode outset and at reporting intervals | <1% | 13 | $172.34 |
| 86592 | <1% | 51 | $159.58 | |
| 90714 | <1% | 26 | $113.33 | |
| 82272 | <1% | 34 | $96.46 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 76 | $81.03 |
| 85384 | <1% | 17 | $77.80 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 95 | $75.20 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 129 | $63.60 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 107 | $56.60 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 205 | $39.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 184 | $36.00 |
| 87449 | <1% | 15 | $31.53 | |
| G8982 | Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 117 | $29.00 |
| 84520 | <1% | 12 | $28.40 | |
| G8981 | Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 87 | $19.00 |
| 94664 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCALANDRIELLO, JOHN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Palisades Medical Associates LLC | North Bergen, NJ | $1.95M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.